The Technical Analyst
Select Language :
Veru Inc [VERU]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Veru Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Veru Inc is listed at the  Exchange

15.39% $0.746

America/New_York / 28 mar 2024 @ 15:37


FUNDAMENTALS
MarketCap: 109.21 mill
EPS: -1.100
P/E: -0.680
Earnings Date: May 09, 2024
SharesOutstanding: 146.38 mill
Avg Daily Volume: 1.771 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.680 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.12x
Company: PE -0.680 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.690 - 0.806

( +/- 7.76%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-10-02 Rankowitz Michael L Buy 90 000 Common Stock Option
2023-10-02 Eisenberger Mario Buy 70 000 Common Stock Option
2023-10-02 Lu Lucy Buy 80 000 Common Stock Option
2023-10-02 Hyun Grace Buy 60 000 Common Stock Option
2023-05-09 Greco Michele Buy 104 000 Common Stock Option
INSIDER POWER
94.36
Last 100 transactions
Buy: 7 521 942 | Sell: 795 000

Forecast: 16:00 - $0.746

Live Trading Signals (every 1 min)

Forecast 1: 15:46 - $0.746
Forecast 2: 16:00 - $0.746
Forecast 3: 16:00 - $0.746
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.746 (15.39% )
Volume 5.58 mill
Avg. Vol. 1.771 mill
% of Avg. Vol 315.12 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Veru Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Veru Inc

RSI

Intraday RSI14 chart for Veru Inc

Last 10 Buy & Sell Signals For VERU

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Veru Inc

VERU

Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company's development drug candidates include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Sabizabulin, which is phase IIb clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Enobosarm + abemaciclib combination therapy, which is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; and Sabizabulin + enobosarm combination therapy, an oral targeted cytoskeleton disruptor plus selective androgen receptor agonist, which is in phase II clinical trial for the treatment of metastatic triple negative breast cancer. Its drug candidates also comprise Sabizabulin, which is in Phase II clinical trial for the treatment of metastatic castration and androgen receptor targeting agent resistant prostate cancer; VERU-100, a GnRH antagonist peptide injection, which is in Phase II clinical trial for the treatment of advanced hormone sensitive prostate cancer; Zuclomiphene Citrate, which is in Phase II clinical trial for treating hot flashes; and Sabizabulin, which is in phase III clinical trial for the treatment of SARS-CoV-2 in subjects at high risk for acute respiratory distress syndrome. In addition, the company is advancing a new drug formulation for the treatment of men with lower urinary tract symptoms from an enlarged prostate. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Last 10 Buy Signals

Date Signal @
SUPERUSDMar 28 - 15:34$1.362
PUNDIXUSDMar 28 - 15:350.668
HOOKUSDMar 28 - 15:341.670
ACMRMar 28 - 15:35$29.15
BLURUSDMar 28 - 15:350.606
GNSUSDMar 28 - 15:305.10
KRYSMar 28 - 15:32$177.33
ULTAMar 28 - 15:31$523.00
TGTXMar 28 - 15:32$15.31
WTAOUSDMar 28 - 15:28547.49

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.